| Bill Tisue, CRNA | |
|
901 Montgomery St, Decorah, IA 52101-2325 | |
| (319) 382-2911 | |
| Not Available |
| Full Name | Bill Tisue |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 901 Montgomery St, Decorah, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972576734 | NPI | - | NPPES |
| 2091348 | Medicaid | IA | |
| 59688 | Other | IA | BLUE CROSS OF IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 047720 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Bill Tisue, CRNA 400 E 10th St, Waconia, MN 55387-4552 Ph: (952) 442-9770 | Bill Tisue, CRNA 901 Montgomery St, Decorah, IA 52101-2325 Ph: (319) 382-2911 |
News Archive
A team of researchers from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa (uOttawa) has been awarded $367,000 from the Canadian Institutes of Health Research (CIHR) and $75,000 from the Stem Cell Network to lead the first clinical trial in the world of a stem cell therapy for septic shock.
Fruit flies are notoriously short-lived but scientists interested in the biology of aging in all animals have begun to understand why some fruit flies live longer than others. They have documented a direct association between insulin and life span, for example, and have observed a tradeoff between prolific reproduction and longevity. A new study, which may have broad implications across species, ties those findings more closely together by tracing an insulin signaling cascade through to protein quality control in muscle tissue and shortened life span.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced publication of data from a preclinical study in a clinically relevant animal model of sepsis showing that recombinant human Interleukin-7 (rhIL-7) treatment not only restores T cell trafficking and function, but also translates into improved survival.
Australia has approved the world's first drug to prolong the lives of people with advanced melanoma. The drug Yervoy received the nod from the Therapeutics Good Association (TGA) on Friday amid hopes it could add two years to the life of people with the deadliest form of skin cancer but for whom other treatments have failed.
› Verified 5 days ago
Christine Sue Roth, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 901 Montgomery St, Decorah, IA 52101 Phone: 563-382-2911 Fax: 563-387-3102 | |
Benjamin Avi Levinson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 901 Montgomery St, Decorah, IA 52101 Phone: 563-382-2911 | |
Lydia Adams, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 901 Montgomery St, Decorah, IA 52101 Phone: 563-382-2911 |